Search alternatives:
significant classes » significant clusters (Expand Search), significant changes (Expand Search), significant cause (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search)
classes based » cases based (Expand Search), clusters based (Expand Search), classified based (Expand Search)
significant classes » significant clusters (Expand Search), significant changes (Expand Search), significant cause (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search)
classes based » cases based (Expand Search), clusters based (Expand Search), classified based (Expand Search)
-
161
Factor analysis based on data provided by males in indoor online class soundscape evaluations.
Published 2024Subjects: -
162
Factor analysis based on data provided by females in indoor online class soundscape evaluations.
Published 2024Subjects: -
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C...
Published 2022“…Inspired by the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …”
-
180
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C...
Published 2022“…Inspired by the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …”